Stock Taper
EARNINGS CALL ARCHIVE 1 CALL ON FILE
ATOS — Atossa Therapeutics, Inc.
NASDAQ
FULL STOCK PAGE →

Q4 2024 Earnings Call Summary

MAR 25, 2025
REVENUE
$0
EPS
-$0.75 +12.9%
FREE CASH FLOW
-$7.1M -48.1%

No summary has been written for this call yet.